Demand surges for anti-HIV injection
There is a rising demand for Lenacapavir, a new injectable medication for HIV prevention, as Nigeria prepares for its nationwide rollout.
Nigeria receives 11,520 doses of Lenacapavir for HIV prevention
Nigeria has received its first batch of 11,520 doses of Lenacapavir, an injectable drug for HIV prevention, donated by the Global Fund.
Nigeria: Nigeria Receives Twice-Yearly HIV Prevention Injection
Nigeria has received its first shipment of the long-acting injectable drug Lenacapavir for HIV prevention, aimed at expanding the country’s prevention options.
South Africa: Bringing It Home - South Africa is Leading the Charge to Make Anti-HIV jab for Africa
South Africa's National Aids Council is soliciting local drug companies to apply for the creation of generic versions of the anti-HIV jab lenacapavir, targeting a goal to end AIDS in the country by 2043.
South Africa wants to produce Lenacapavir, a preventive treatment against HIV
South Africa aims to locally produce Lenacapavir, a revolutionary preventive treatment for HIV, which has just begun to be administered on the continent.
South Africa pushes for local production of HIV prevention drug lenacapavir
South Africa is aiming to produce the HIV prevention drug lenacapavir locally to enhance treatment access and support its pharmaceutical sector.
FG confirms March arrival of HIV prevention injection
Nigeria is set to receive Lenacapavir, a significant HIV prevention injection, in March, which has shown 100% efficacy in clinical trials.
Nigeria: Nigeria to Receive Twice-Yearly HIV Prevention Injection in March - Official
Nigeria is set to receive a new HIV prevention injection called Lenacapavir in March 2026 as part of efforts to reduce new infections.
Kenya to Offer Patients Free Six-Month HIV 'Breakthrough' Prevention Jab
Kenya has begun providing lenacapavir, a long-acting injectable HIV prevention drug, free of charge to eligible patients, marking a significant advancement in the fight against HIV.
Kenya administers the first injections of a preventive treatment against HIV
Kenya has launched the use of a new injectable preventive treatment against HIV called lenacapavir, marking a significant advance in HIV prevention methods.
Kenya administers HIV prevention drug
Kenya has started administering LENACAPAVIR, a revolutionary long-acting HIV prevention drug, marking a significant step in the fight against HIV/AIDS.
Kenya Administers First HIV Prevention Shots
Kenya has begun administering lenacapavir, a new HIV prevention drug, as part of its efforts to combat the HIV epidemic.
Zimbabwe roll-out of long-acting HIV prevention drug gets underway
Zimbabwe has started administering lenacapavir, a long-acting HIV prevention drug, aimed at significantly reducing infections among high-risk groups.
Zimbabwe: New HIV Injection to Reach 271,000 Zimbabweans in Major US-Backed Drive
The US will support 271,000 Zimbabweans in accessing a new biannual HIV prevention injection as part of a campaign to combat the disease.
Zimbabwe launches groundbreaking HIV prevention drug Lenacapavir
Zimbabwe has launched a national program for Lenacapavir, a twice-yearly injectable HIV prevention drug, marking a significant step in its fight against AIDS.
Kenya to roll out game-changing HIV drug in March
Kenya will introduce a new HIV-prevention drug, Lenacapavir, in March, significantly reducing transmission risks.
Kenya to roll out HIV prevention shots in March
Kenya is set to launch a new HIV prevention drug, lenacapavir, in March, which has proven to reduce the risk of HIV transmission significantly.
Kenya Receives 21,000 Doses of Long-Acting HIV Prevention Drug Ahead of March Rollout
Kenya has received 21,000 doses of the long-acting injectable HIV prevention drug Lenacapavir, set to be rolled out across the country starting March 2026.
Nigeria: Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria - the Real Test Is Access
The World Health Organization has recommended twice-yearly lenacapavir injections for HIV prevention in Nigeria, emphasizing the importance of access and equity in implementing this treatment option.